III/IV resectable melanoma remained event-free at four years from the start of neoadjuvant systemic treatment.

A breakthrough AI system is revolutionizing cancer immunotherapy by enabling scientists to design protein-based keys that ...

Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope ...

A team used generative AI to enhance T cells’ ability to fight melanoma. The immunotherapy approach needs more testing before use in cancer patients.

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of ...

AbbVie has struck an immuno-oncology licensing agreement with IGI Therapeutics that is potentially worth more than $1.9 billion to the clinical-stage biotechnology company.

Lee is hopeful about a future in which ivermectin may be incorporated into immunotherapy cancer treatment. “As a stand-alone, ivermectin is not a miracle drug for cancer,” he says.

In cancer, a novel T cell therapy has emerged in the last few decades. This treatment is known as chimeric antigen receptor-T cell (CAR-T cell) therapy. This form of treatment is an immunotherapy, ...

A University of Alberta research team has identified a DNA structure that activates the immune system in cancer cells that are usually resistant to immunotherapy, offering hope of new, more ...

TEVA teams up with Fosun to speed the development of TEV-56278, a novel anti-cancer immunotherapy targeting PD-1+ T cells.